Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Genzyme’s Richard Moscicki joins FDA

Provides regulatory agency with more than 20 years of industry experience

- PMLiVE

Merck & Co extends autoimmune collaboration with Lycera

New deal could be worth more than $300m to the US biopharma company

- PMLiVE

FDA fast-tracks Bayer’s prostate cancer radiotherapy

Priority review for radium-223 dichloride, formerly called Alpharadin

- PMLiVE

Building brand strength – Part 4

Commitment, responsiveness and protection – how far will Big Pharma go to preserve its brands?

- PMLiVE

Havas PR appoints new director of health and wellness

Louise Stone has worked with Lexus PR, Nexus Communications and Good Relations

- PMLiVE

David Cameron wants UK to become more ‘dementia friendly’

Prime minister takes part in first DH sponsored Dementia Friends session

Novartis building

Novartis’ Jakavi turned down by NICE for blood cancer

UK cost-effectiveness watchdog concerned about 'uncertainties' in data in draft guidance

- PMLiVE

Teva wins challenge to BMS’ Baraclude patent in US

US court says hepatitis B treatment’s patent is invalid

- PMLiVE

New UK guidance on data protection in pharmacovigilance

In a guest blog the ABPI's Esteban Herrero-Martinez sets out some key steps for pharma companies to consider

- PMLiVE

BMS licenses OTC rights to Reckitt for $482m

Will market products including Picot, Tempra and Graneodin in Latin America

Mylan appoints two new board members

Melina Higgins is a former partner at Goldman Sachs and Rajiv Malik is president at Mylan

- PMLiVE

UCB-Amgen pull development of drug to heal fractures

But romosozumab remains on course in postmenopausal osteoporosis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links